JNJ

186.79

+0.34%↑

ABT

125.77

+1.66%↑

TMO

565.15

+0.26%↑

ISRG

538.71

-0.99%↓

DHR

213.79

-0.14%↓

JNJ

186.79

+0.34%↑

ABT

125.77

+1.66%↑

TMO

565.15

+0.26%↑

ISRG

538.71

-0.99%↓

DHR

213.79

-0.14%↓

JNJ

186.79

+0.34%↑

ABT

125.77

+1.66%↑

TMO

565.15

+0.26%↑

ISRG

538.71

-0.99%↓

DHR

213.79

-0.14%↓

JNJ

186.79

+0.34%↑

ABT

125.77

+1.66%↑

TMO

565.15

+0.26%↑

ISRG

538.71

-0.99%↓

DHR

213.79

-0.14%↓

JNJ

186.79

+0.34%↑

ABT

125.77

+1.66%↑

TMO

565.15

+0.26%↑

ISRG

538.71

-0.99%↓

DHR

213.79

-0.14%↓

Search

Prestige Consumer Healthcare

Closed

SectorHealthcare

60.54 0.13

Overview

Share price change

24h

Current

Min

59.52

Max

60.63

Key metrics

By Trading Economics

Income

-2.7M

47M

Sales

-47M

250M

P/E

Sector Avg

14.561

37.003

Profit margin

19.022

Employees

600

EBITDA

-5.8M

80M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+33.29% upside

Dividends

By Dow Jones

Next Earnings

6 lis 2025

Market Stats

By TradingEconomics

Market Cap

-592M

3.1B

Previous open

60.41

Previous close

60.54

News Sentiment

By Acuity

50%

50%

156 / 373 Ranking in Healthcare

Prestige Consumer Healthcare Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

3 lis 2025, 21:44 UTC

Earnings

Vertex Pharmaceuticals Revenue Climbs on Demand for Cystic Fibrosis Drugs

3 lis 2025, 23:44 UTC

Market Talk

Nikkei May Rise on Weaker Yen, Hopes for Govt Econ Steps -- Market Talk

3 lis 2025, 23:34 UTC

Market Talk

Gold Edges Lower Amid Lingering Worry Over China's Ending of Tax Incentive -- Market Talk

3 lis 2025, 23:28 UTC

Earnings

Palantir Revenue Hits Another Record as Defense Work Booms -- 2nd Update

3 lis 2025, 23:24 UTC

Earnings

Correct: Grab Holdings Sees FY2025 Adj Ebitda $490M-$500.0M, Higher Than $460M-$480M Projected in 2Q >GRAB

3 lis 2025, 23:14 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Global Equities Roundup: Market Talk

3 lis 2025, 23:14 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Deterra's Next CEO Might Bring New Approach to Deals -- Market Talk

3 lis 2025, 23:12 UTC

Earnings

Grab Holdings Sees FY2025 Adj Ebitda $490-$500.0M, Higher Than $460M-$480M Projected in 2Q >GRAB

3 lis 2025, 23:09 UTC

Earnings

Grab Holdings 3Q 2Q Adj EBITDA $136.0M Vs. $90.0M>GRAB

3 lis 2025, 23:09 UTC

Earnings

Grab Holdings 3Q Net $17.0M Vs. Net $15.0M >GRAB

3 lis 2025, 23:09 UTC

Earnings

Grab Holdings 3Q Rev $873.0M Vs. $716.0M >GRAB

3 lis 2025, 23:06 UTC

Market Talk
Earnings

Palantir Execs Forecast Future of U.S. Workers In AI World -- Market Talk

3 lis 2025, 22:36 UTC

Market Talk
Earnings

Palantir's U.S. Commercial Business Booms as It Expands AI -- Market Talk

3 lis 2025, 22:31 UTC

Earnings

Franco-Nevada 3Q EPS $1.49 >FNV

3 lis 2025, 22:31 UTC

Earnings

Franco-Nevada 3Q Rev $487.7M >FNV

3 lis 2025, 22:24 UTC

Market Talk

Xero Bulls Expect Improving U.S. Momentum in 1H -- Market Talk

3 lis 2025, 22:19 UTC

Acquisitions, Mergers, Takeovers

Starbucks Agrees to Sell Stake in China Business -- WSJ

3 lis 2025, 21:59 UTC

Market Talk

RBA Set To Keep Rates On Hold; Remain Data Dependent -- Market Talk

3 lis 2025, 21:54 UTC

Market Talk
Earnings

Westpac's Tech Challenge Keeps Jefferies Cautious -- Market Talk

3 lis 2025, 21:54 UTC

Market Talk
Earnings

Global Equities Roundup: Market Talk

3 lis 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

3 lis 2025, 21:49 UTC

Earnings

Palantir Revenue Hits Another Record as Defense Work Booms -- Update

3 lis 2025, 21:40 UTC

Earnings

Barry Diller's IAC Inks AI Deal With Microsoft. That Isn't Why the Stock Is Sliding. -- Barrons.com

3 lis 2025, 21:31 UTC

Market Talk

Mexican Manufacturing Indexes Pick Up in October -- Market Talk

3 lis 2025, 21:19 UTC

Earnings

Palantir Revenue Hits Another Record as Defense Work Booms -- WSJ

3 lis 2025, 21:11 UTC

Acquisitions, Mergers, Takeovers

Pfizer Reports Earnings Tuesday. Management Has Big Questions to Answer. -- Barrons.com

3 lis 2025, 21:11 UTC

Earnings

Diamondback Energy: Increasing Full Yr Oil Production Guidance to 495-498 MBO/d and Increasing Annual BOE Guidance to 910-920 MBOE/d >FANG

3 lis 2025, 21:07 UTC

Earnings

Palantir Technologies: Raising 2025 U.S. Comml Rev Guidance to in Excess of $1.433B, Representing a Growth Rate of at Least 104% >PLTR

3 lis 2025, 21:05 UTC

Earnings

Vertex Pharmaceutic Sees 2025 Rev $11.9B-$12B >VRTX

3 lis 2025, 21:05 UTC

Earnings

Palantir Technologies 3Q Net $475.6M >PLTR

Peer Comparison

Price change

Prestige Consumer Healthcare Forecast

Price Target

By TipRanks

33.29% upside

12 Months Forecast

Average 80.75 USD  33.29%

High 100 USD

Low 71 USD

Based on 5 Wall Street analysts offering 12 month price targets forPrestige Consumer Healthcare - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

5 ratings

4

Buy

1

Hold

0

Sell

Sentiment

By Acuity

156 / 373 Ranking in Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers analgesic powders under the BC and Goody's brand; diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and Debrox for ear wax removal. The company also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; Dramamine for motion sickness relief; enemas and other laxative products under the Fleet brand name; Gaviscon for upset stomach; cough drops under the Luden's brand; Monistat for yeast infections in women; Nix for lice and parasite treatments; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; TheraTears for dry eyes; nasal saline sprays and washes under the Fess brand name; and Hydralyte for oral rehydration. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
help-icon Live chat